Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Combination With Platinum-Based Doublet Chemotherapy (PT-DC) in Advanced Non-Small Cell Lung Cancer (NSCLC)

Authors :: Scott A. Laurie
Laura Q.M. Chow
Allen C. Chen
Yun Shen
Frances A. Shepherd
Rosalyn A. Juergens
Hossein Borghaei
David E. Gerber
Christopher T. Harbison
Jonathan H. Goldman
Naiyer A. Rizvi
Scott J. Antonia
Scott N. Gettinger
Julie R. Brahmer
Source :: International Journal of Radiation Oncology*Biology*Physics. 90:S2
Publication Year :: 2014
Publisher :: Elsevier BV, 2014.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Chemotherapy
Radiation
business.industry
medicine.medical_treatment
Anti pd 1
non-small cell lung cancer (NSCLC)
chemistry.chemical_element
medicine.disease
chemistry
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
Nivolumab
Platinum
business

Tools